Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma-Reference-Cited by-同舟云学术

Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma

Published:2019-11-14 Issue:11 Volume:5 Page:e192553
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Arrieta Oscar¹,Barrón Feliciano¹,Padilla Miguel-Ángel Salinas¹,Avilés-Salas Alejandro¹,Ramírez-Tirado Laura Alejandra¹,Arguelles Jiménez Manuel Jesús¹,Vergara Edgar¹,Zatarain-Barrón Zyanya Lucia¹,Hernández-Pedro Norma¹,Cardona Andrés F.²³⁴,Cruz-Rico Graciela¹,Barrios-Bernal Pedro¹,Yamamoto Ramos Masao⁵,Rosell Rafael⁶

Affiliation:

1. Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico

2. Clinical and Translational Oncology Group, Clínica del Country, Bogotá, Colombia

3. Foundation for Clinical and Applied Cancer Research (FICMAC), Bogotá, Colombia

4. Clinical Research and Biology Systems Department, Universidad el Bosque, Bogotá, Colombia

5. Department of Radiology and Imaging, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico

6. Catalan Institute of Oncology, Germans Trias i Pujol Research Institute and Hospital Campus Can Ruti, Barcelona, Spain

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2749256/jamaoncology_arrieta_2019_oi_190057.pdf

Reference32 articles.

1. Cancer statistics, 2018.;Siegel;CA Cancer J Clin,2018

2. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007.;Walters;Thorax,2013

3. Personalized medicine in lung cancer: what we need to know.;Mok;Nat Rev Clin Oncol,2011

4. Updated frequency of EGFR and KRAS mutations in non–small-cell lung cancer in Latin America: the Latin-American Consortium for the Investigation of Lung Cancer (CLICaP).;Arrieta;J Thorac Oncol,2015

5. Lung cancer: current therapies and new targeted treatments.;Hirsch;Lancet,2017

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin: A potential adjunct for treatment of systemic mastocytosis;Journal of Allergy and Clinical Immunology: Global;2024-02

2. Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS‐010759;Molecular Oncology;2024-01-12

3. Research Status of Anti-Aging Drugs in Non-Small Cell Lung Cancer;Advances in Clinical Medicine;2024

4. Targeting TAM-secreted S100A9 effectively enhances the tumor-suppressive effect of metformin in treating lung adenocarcinoma;Cancer Letters;2024-01

5. Mitochondrion: Main organelle in orchestrating cancer escape from chemotherapy;Cancer Reports;2023-12-27